RT Journal Article
SR Electronic
T1 Dimensionality and homogeneity of the Colombian version of the Cocaine Craving Questionnaire (CCQ-N-10)
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.12.07.21267420
DO 10.1101/2021.12.07.21267420
A1 Carlos Arturo Cassiani-Miranda
A1 Orlando Scoppetta
A1 Tito Cesar Quintero-Gómez
A1 Eduard Arraut-Camargo
A1 Guillermo Castaño-Pérez
A1 Diego Fernando Cabanzo-Arenas
A1 Adalberto Campo-Arias
YR 2021
UL http://medrxiv.org/content/early/2021/12/08/2021.12.07.21267420.abstract
AB Background and aim It is essential to have a validated instrument to measure craving for cocaine use. However, in Colombia, there is no instrument to screen cocaine craving. The study aimed to determine the homogeneity and dimensionality of the CCQ-N-10 in patients with cocaine use disorder in Colombia.Materials and methods An adaptation and subsequent analysis of the psychometric properties of the CCQ-N-10 scale was carried out with 102 hospitalized or outpatient adults diagnosed with substance use disorders in addiction units in Bucaramanga, Colombia. Internal consistency and construct validity were estimated by confirmatory factor analysis and correlation analysis with scales with similar objectives.Results An omega coefficient of 0.93 was obtained, and adjustment indicators of the confirmatory model were acceptable (RMSEA of 0.08, CFI and TLI of 0.99) when two of the original scale items were removed from the original scale analysis.Conclusions This study shows that the craving scale reduced to eight items can be helpful to assess the construct in the Colombian population; However, the small sample size makes it challenging to carry out other analyzes to corroborate its psychometric properties.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by the Universidad de Santander (FI46-19).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee and the research department of the Universidad de SantanderI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the corresponding author.